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Background: Although the surface area metric has been proposed as a possible dose-metric for nanoparticles
(NPs), it is limited to low-solubility NPs and the dose-metric for high-solubility NPs is poorly understood. In this
study, we aimed to assess the appropriate dose-metric or response-metric for NPs using two cobalt (Co)-based
NPs, cobalt monoxide (CoO) and cobalt oxide (Co3O4), which both show distinctive solubility, and determine the
role of their soluble Co ions in inflammation.
Methods: We evaluated the physicochemical properties of NPs, including solubility in artificial lysosomal fluid
(ALF, pH 5.5). Acute lung inflammogenicity was evaluated by bronchoalveolar lavage fluid analysis using the
rat intratracheal instillation model. The appropriate response-metric was then determined by plotting several
dose-metrics against parameters for lung inflammation. To investigate the effect of the soluble fraction of CoO
NPs, the equivalent doses of Co ions from CoCl2 were instilled.
Results: The Co3O4 and CoO NPs showed about 11.46 % and 92.65 % solubility in ALF, respectively. Instillation
of Co3O4 NPs produced neutrophilic inflammation, but CoO NPs induced eosinophilic inflammation. The number
of eosinophils showed good correlation with the soluble Co ions dose from NPs (r2 = 0.987, p <0.001), while the
number of neutrophils showed good correlation with the surface area dose of the biopersistent NPs (r2 = 0.876,
p <0.001). Instillation of CoCl2 showed a similar type and magnitude of inflammation as CoO NPs.
Conclusions: In the Co-based NPs, the eosinophilic inflammation was produced by Co ions based on the ion
metric, while the neutrophilic inflammation was developed based on the surface area metric of the biopersistent NPs.
Keywords: Dose-metric, High solubility nanoparticles, Ion metric, Co3O4, CoO, Intratracheal instillationBackground
The selection of an appropriate dose-metric for nanoma-
terials (NMs) is important for evaluating their toxicity and
assessing their risk [1]. Mass, surface area (SA), and
number are the possible candidates for dose-metrics
for the particulate form of NMs, while the number of
fibers of a specific length is an additional candidate for the
dose-metric of high aspect ratio NMs (HARNs) [2, 3].
Most studies used lung inflammation models (generally by
intratracheal instillation), because the lung is very sensitive
to both acute and chronic inflammation and is essentially
a closed chamber with very few fraction of the instilled
NPs that translocate into the systemic circulation [4].* Correspondence: wcho@dau.ac.kr
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unless otherwise stated.For example, instillation of gold NPs larger than
5 nm diameter showed less than 1 % extrapulmonary
translocation [4]. In an intratracheal instillation model,
the SA metric for low-solubility NPs has been proposed as
a better metric than either mass or number [5–7]. Under
a SA metric, the number of neutrophils of low-solubility
low-toxicity NPs showed an overlapped dose–response
curve, while intrinsic factors such as surface reactivity
contribute to the slope of the curves for low-solubility
high-toxicity NPs [5, 7].
Although NPs are rarely soluble in normal physiological
environments such as in the interstitial fluid, some NPs
such as zinc oxide (ZnO), copper oxide (CuO), and silver
(Ag) have considerable solubility in acidic environments
such as lysosomal and gastric fluid [8–10]. High-solubility
NPs composed of toxic elements generally show higher
toxicity than low-solubility NPs of the same compositionalThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Physicochemical characterization of nanoparticles
Measure Co3O4 CoO
Primary size (nm) 20.2 ± 0.4 65.4 ± 2.8
Hydrodynamic size (nm)
in DW 93.4 ± 1.8 380.3 ± 14.4
in PBS 468.9 ± 24.3 449.1 ± 8.9
Polydispersity
in DW 0.18 ± 0.03 0.72 ± 0.02
in PBS 0.26 ± 0.02 0.69 ± 0.05
Surface area (m2/g) 35.8 8.5
Zeta potential (mV)
in DW 39.53 ± 0.72 6.99 ± 1.18
in PBS (pH 7.4) −26.40 ± 0.90 −21.80 ± 0.45
Solubility (%) in ALF 11.46 92.65
Solubility (%) in PBS 0.02 4.12
Endotoxin ND ND
Data were presented as mean ± SEM
ND, not detected
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[11]. In recent studies, high-solubility ZnO, CuO, and
Ag NPs showed acute eosinophilic inflammation with
increased cytotoxicity due to their solubilized compositional
ions in the rat intratracheal instillation model, while
medium-solubility nickel oxide (NiO) and cobalt oxide
(Co3O4) NPs caused acute neutrophilic inflammation with
immunological responses in the chronic phase, such as
delayed type hypersensitivity [8, 12, 13]. Therefore, the
evaluation of the differential effects of soluble fraction and
biopersistent NPs, using NPs with the same compositional
elements but different solubility, might provide important
information on the role of solubility in NP toxicology.
Unlike low-solubility NPs, the dose-metric for high-
solubility NPs is poorly understood. The first in evaluating
the dose-metrics for high-solubility NPs could be the
comparison of acute lung inflammogenicity using two
NPs with the same compositional elements but different
solubility. The next step would then be to compare the
dose–response relationship between the high solubility
NPs (e.g., Ag, CuO, and ZnO) by normalizing the observed
values with the weighed toxicity value of the solubilized
ions (e.g., AgCl2, CuCl2, and ZnCl2). In this study, we
obtained two cobalt-based NPs, cobalt monoxide (CoO)
and cobalt oxide (Co3O4), having a distinct difference in
solubility in artificial lysosomal fluid. We then evaluated
the role of soluble fraction and biopersistent NPs in
acute lung inflammation, using an intratracheal instillation
model, to investigate the appropriate response-metric for
acute lung inflammation by cobalt-based NPs.
Results
Characterization of NPs
The physicochemical properties of NPs are presented in
Table 1. The average size of Co3O4 and CoO NPs
measured by transmission electron microscopy (TEM)
were 20.2 and 65.4 nm, respectively. TEM images
showed that both NPs were spherical without porous
structure (Fig. 1). The hydrodynamic size of NPs
showed that both NPs showed a “hard agglomerates”
in both distilled water (DW) and phosphate-buffered
saline (PBS). Co3O4 NPs were less agglomerated than
CoO NPs when dispersed in DW, while both NPs
showed similar size range about 450 nm when dispersed
in PBS (Table 1). Polydispersity showed that Co3O4
NPs were more homogenous than CoO NPs. The zeta
potentials of both NPs were positive in DW but nega-
tive in PBS, which may be due to the neutral pH of
PBS. Incubation of Co3O4 and CoO NPs in artificial
lysosomal fluid (ALF) showed 11.46 % and 92.65 %
solubility, respectively. Solubility of NPs in PBS was
minimal at 0.02 % and 4.12 % for Co3O4 and CoO
NPs, respectively. Both NPs showed no endotoxin
contamination.Cytological evaluation of lung inflammogenicity
Instillation of Co3O4 NPs at the high dose produced
significant increases in the total number of cells
(45.60 ± 7.71, × 105) and neutrophils (25.65 ± 4.80, ×105)
compared to the vehicle control, but the number of
macrophages, eosinophils, and lymphocytes were com-
parable to vehicle control (Table 2). Treatment of CoO
NPs significantly increased the number of macrophages at
the mid dose and eosinophils (3.37 ± 1.23, ×105) at the
high dose (Table 2).
Lactate dehydrogenase (LDH) and total protein
The levels of LDH by Co3O4 NPs were significantly
increased only at high dose (400 μg/rat). However, the
levels of LDH in CoO NPs were significantly increased in
all treatment groups in a dose-dependent manner (Table 2).
The fold increase of LDH in CoO NPs (9.21 ± 0.30) at
400 μg/rat showed much higher level than Co3O4 NPs
(3.47 ± 0.15) at the same dose (Table 2). The concentra-
tions of total protein were significantly increased by the
mid- and high-dose group of CoO NPs, while Co3O4 NPs
showed no significant increases (Table 2).
Expression of pro-inflammatory cytokines in
bronchoalveolar lavage fluid (BALF)
Among the 6 pro-inflammatory cytokines measured in
BALF, treatment with Co3O4 NPs significantly increased
cytokine-induced neutrophil chemoattractant-3 (CINC-3)
levels only, while CoO NPs significantly increased the
levels of interleukin-6 (IL-6), eotaxin, and IL-13 in a dose-
dependent manner (Table 2). IL-1β and tumor necrosis
factor-α (TNF-α) showed no significant changes in either
treatment groups (data not shown).
Fig. 1 Transmission electron microscopy (TEM) image of (A) cobalt oxide (Co3O4) and (B) cobalt monoxide (CoO) nanoparticles (NPs). Both Co3O4
and CoO NPs showed spherical shape without porous structure
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CoO NPs
To evaluate the effect of dissolved Co ions, we instilled
cobalt chloride (CoCl2) dissolved in sterile saline into
the lungs of rats at an equivalent Co ion dose for CoO
NPs. Treatment of CoCl2 showed significant increases in
the number of neutrophils and eosinophils, the levels of
LDH and total protein, and the levels of IL-6 and eotaxin
in BALF compared to the vehicle control (Table 3). Based
on the equivalent dose of Co ions (31, 79, and 315 μg/rat),
the data from CoCl2 produced similar dose–response
curves compared to the CoO NPs in various inflammatory
markers including the inflammatory cells, LDH, total
protein, IL-6, and eotaxin (Fig. 2).
Correlation between dose-metrics and inflammatory
parameters
To evaluate the best-fit dose–response curve, various
dose-metrics, including mass, SA, fraction of soluble Co
ions, and SA of biopersistent NPs, were plotted againstTable 2 Summary of inflammatory cell counts, LDH, total protein, an
of NPs
BALF measure VEHPBS Co3O4 dose (μg/rat)
40 100
Total cells (× 105) 10.95 ± 1.42 23.60 ± 3.64 20.48 ± 5.59
Macrophages (× 105) 10.34 ± 1.19 23.21 ± 3.55 16.67 ± 4.63
Neutrophils (× 105) 0.49 ± 0.39 0.38 ± 0.10 3.79 ± 3.13
Eosinophils (× 105) 0.07 ± 0.02 0.00 ± 0.00 0.01 ± 0.01
Lymphocytes (× 105) 0.05 ± 0.05 0.02 ± 0.02 0.00 ± 0.00
LDH (fold vs control) 1.00 ± 0.05 1.23 ± 0.10 1.62 ± 0.17
Total protein (μg/mL) 301 ± 5 118 ± 14 335 ± 116
CINC-3 (pg/mL) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
IL-6 (pg/mL) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Eotaxin (pg/mL) 5.7 ± 1.2 4.5 ± 1.5 67.4 ± 57.4
IL-13 (pg/mL) 17.7 ± 1.9 22.6 ± 4.2 28.9 ± 4.5
Data were presented as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001, statistical
VEHPBS, Ca
2+-and Mg2+-free PBS was used as VEH for NPs; LDH, lactate dehydrogenthe acute lung inflammatory parameters produced by
Co3O4 and CoO treatment. When the number of
eosinophils from each NP was plotted against mass,
SA, or SA of biopersistent NPs, each NP showed a separate
dose–response curve, while the dose–response curves
from two NPs overlapped when they were plotted against
soluble Co ions (r2 = 0.987, p < 0.001) (Fig. 3A-D). When
the number of neutrophils from each NP was plotted
against various dose-metrics, only the SA dose of
biopersistent NPs showed good correlation (r2 = 0.876,
p < 0.001), while other dose-metrics showed separate
curves (Fig. 3E-H). In line with the dose–response curves
of eosinophils, the dose–response curves of LDH and total
protein from NPs overlapped when they were plotted
against the soluble Co ion dose, while other dose-metrics
showed separate curves (Fig. 4).
Discussion
Selection of an appropriate dose-metric for NMs is critical
for the evaluation of toxicity and risk assessment. Thed inflammatory mediators at 24 h after intratracheal instillation
CoO dose (μg/rat)
400 40 100 400
45.60 ± 7.71*** 18.90 ± 2.40 30.53 ± 0.39 23.25 ± 4.10
19.82 ± 3.27 17.58 ± 1.81 24.46 ± 2.64* 11.83 ± 3.03
25.65 ± 4.80*** 1.18 ± 1.06 4.91 ± 2.02 8.02 ± 1.85
0.09 ± 0.05 0.10 ± 0.10 1.16 ± 0.76 3.37 ± 1.23**
0.05 ± 0.05 0.03 ± 0.03 0.00 ± 0.00 0.04 ± 0.04
3.47 ± 0.15*** 2.35 ± 0.08*** 5.41 ± 0.22*** 9.21 ± 0.30***
253 ± 18 99 ± 5 1104 ± 77* 3767 ± 667***
110.4 ± 39.4** 0.00 ± 0.00 27.3 ± 27.3 0.00 ± 0.00
0.00 ± 0.00 0.00 ± 0.00 123.4 ± 43.6 982.0 ± 349.4***
22.5 ± 10.6 4.5 ± 1.8 265.7 ± 68.9 2963.9 ± 870.7***
16.9 ± 6.0 35.8 ± 4.9 49.0 ± 9.7 108.5 ± 15.6***
ly different from vehicle control (VEHPBS)
ase; CINC-3, cytokine-induced neutrophil chemoattractant-3
Table 3 Summary of inflammatory cell counts, LDH, total protein, and inflammatory mediators at 24 h after intratracheal instillation
of CoCl2
BALF measure VEHsaline CoCl2 (μg/rat)
a
69 (31)b 173 (79) 693 (315)
Total cells (× 105) 13.65 ± 2.63 24.68 ± 5.12 28.35 ± 3.96 18.30 ± 1.54
Macrophages (× 105) 11.84 ± 1.36 14.12 ± 1.81 13.66 ± 0.80 2.92 ± 0.746**
Neutrophils (× 105) 1.76 ± 1.38 10.48 ± 3.72* 13.74 ± 3.77** 11.70 ± 2.75***
Eosinophils (× 105) 0.02 ± 0.02 0.06 ± 0.04 0.95 ± 0.56 3.63 ± 0.81**
Lymphocytes (× 105) 0.05 ± 0.01 0.10 ± 0.04 0.04 ± 0.02 0.02 ± 0.02
LDH (fold vs control) 1.00 ± 0.12 3.08 ± 0.53* 6.65 ± 0.78*** 15.05 ± 0.18***
Total protein (μg/mL) 270 ± 47 341 ± 67 700 ± 165 5051 ± 917***
CINC-3 (pg/mL) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
IL-6 (pg/mL) 0.00 ± 0.00 0.00 ± 0.00 39.2 ± 39.2 734.6 ± 152.3***
Eotaxin (pg/mL) 10.76 ± 3.27 30.94 ± 16.60 133.1 ± 49.2 699.8 ± 38.1***
IL-13 (pg/mL) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
aCo ions were prepared by dissolving CoCl2 in saline and treated at equivalent dose for Co of CoO NPs (40, 100, and 400 μg/rat)
bParenthesis represents the Co ions mass for CoCl2 which is equivalent Co ions doses of CoO NPs
Data were presented as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001, statistically different from vehicle control (VEHsaline)
VEHsaline, sterile 0.9 % saline was used as a vehicle control for CoCl2; LDH, lactate dehydrogenase; CINC-3, cytokine-induced neutrophil chemoattractant-3
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that produce the response. Therefore, the dose-metric of
NMs can be variable depending on the biologically
effective dose (BED), which is the component of the
total dose that produces adverse effects [2]. The BED
is influenced not only by the intrinsic characteristics
of NMs, including size, shape, soluble fraction, and
biopersistence, but also by the extrinsic factors including
route of exposure. Among them, the inhalation route is
well studied, and SA and number of fibers with specific
length were proposed as a proper dose-metric for NPs
and fibers, respectively [2]. Although the SA metric has
been proposed as a dose-metric for NPs, it is limited to
low-solubility NPs such as titanium dioxide and carbon
black [5, 6]. Based on the SA dose-metric, the slope of the
dose–response curve of low-solubility NPs is dependent
on the surface reactivity, such as zeta potential and reactive
oxygen species generation potential [7, 8]. However, the
dose-metric for high-solubility NPs was poorly understood,
although the soluble fraction was known as one of the
main factors that influence the BED [14, 15].
Most NPs are rarely soluble at normal physiological
conditions, but solubility can be accelerated in acidic
conditions, such as in the lysosomal fluid inside cells
[16, 17]. Therefore, the significant solubility of NPs in
ALF shown in this study is solely due to the chemical
reaction. However, further study is needed for the
development of a biopersistence assay using a cell-based
model or in vivo condition because the biodegradation of
NPs can also be accelerated by the enzyme-catalyzed
reaction [18, 19]. The dissolution of NPs results in the loss
of their surface reactivity, and thus the factors inducing
toxicity may depend on the toxicity of their compositionions. Therefore, the SA metric cannot be applied to
high-solubility NPs and another proper dose-metric
should be considered. Moreover, because the toxicity
of high-solubility NPs such as zinc oxide (ZnO) and
copper oxide (CuO) were known to cause higher
inflammogenicity and cytotoxicity in the acute phase
with severe eosinophilic inflammation, a proper dose-
metric is very important for risk assessment [20]. Here, we
used Co3O4 and CoO, two types of cobalt-based NPs,
which have similar types of soluble fractions but different
solubility, to evaluate the dose-metric or response-metric
for acute lung inflammogenicity.
The Occupational Safety and Health Administration
(OSHA) regulated the 8-h permissible exposure limit
(PEL) for cobalt metal, dust, and fumes as 0.1 mg/m3
[21]. The retained mass of 100 μg in the lung, the mid dose
in this study, would be reached from 28 days (6 h/day) of
nasal exposure to a 0.1 mg/m3 cloud of NPs with
aerodynamic diameter of 50 nm (typical primary size of
NPs used in this study) according to the Multiple-Path
Particle Dosimetry (MPPD) deposition model [22]. In our
previous study, we found that high solubility NPs can
produce acute eosinophilic inflammation but the dose was
critical for determining the type of inflammation [8]. Acute
eosinophilic inflammation was also reported in the case of
an accidental exposure of ZnO to human [23]. Although
the bolus deliveries of NPs at a high dose which can
be reached after a repeated inhalation scenario do not
reflect physiological condition, the high dose used in this
study (400 μg/rat) can be a realistic dose for occupational
exposure.
In this study, medium-solubility Co3O4 NPs produced a
dose-dependent neutrophilic influx, while high-solubility
Fig. 2 Comparison of inflammatory parameters for cobalt monoxide (CoO) nanoparticles (NPs) and cobalt chloride (CoCl2). Number of (A) total
cells, (B) macrophages, (C) neutrophils, (D) eosinophils, and levels of (E) LDH, (F) total protein, (G) IL-6, and (H) eotaxin. Both treatment groups
had same doses for cobalt ions (31, 79, and 315 μg/rat). Note that the inflammatory parameters of CoO NPs were similar with the CoCl2 which
implies that the toxicity of CoO NPs was derived from their solubilized cobalt ions. Values are mean ± SEM (n = 4) for each treatment group. The
data from CoO NPs were compared with the vehicle control (Ca2+- and Mg2+-free phosphate buffered saline) to determine statistical significance.
*p < 0.05, **p < 0.01, ***p < 0.001. The data from CoCl2 were compared with the vehicle control (0.9 % saline).
$p < 0.05, $$p < 0.01, $$$p < 0.001
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24 h after treatment. In our previous studies, intratracheal
instillation of high-solubility NPs such as ZnO and CuO
NPs produced an acute eosinophilia in the lung without
any previous sensitization [16, 20, 24]. In this study,
the inflammatory potentials of CoO NPs, evaluated by
counting cells or measuring cytokines in the BALF,
were comparable to ones evaluated after treatment with
an identical Co ion mass of CoCl2, although there was
some variation in the number of macrophages and the
levels of LDH, IL-6, and eotaxin. Therefore, the eosino-
philic inflammation produced by CoO NPs was originated
from the dissolution of Co ions present inside lysosomes,
which is the same mechanism of action as ZnO NPs [16,
25]. This eosinophilic inflammation was mediated by
direct induction of eotaxin but the underlying mecha-
nisms were poorly understood. One possible mechanism
for non-IgE mediated allergic response is the activation of
anaphylatoxins such as C3a and C5a which was reported
in some liposomal NPs (e.g., Doxil) and micellar NPs(e.g., Taxol) [26]. However, that mechanism was not
known for the acute eosinophilic inflammation by
metal oxide NPs which warrants further investigation.
In previous studies, SA has been proposed as a dose-
metric for low-solubility NPs in the acute pulmonary
inflammation model [5, 27, 28]. For nanofibers, the num-
ber of fibers with a specific length has been proposed as
one of the main factors contributing to lung inflammation
[29–31]. However, the dose-metric for high-solubility NPs
has not been reported yet. According to the results from
this study, the ion dose-metric can be used for eosino-
philic inflammation, cell death, and vascular permeability,
because the number of eosinophils and levels of LDH or
total protein produced by Co3O4 and CoO NPs had an
overlapping dose–response curve when it was plotted
against the dose of Co ions. In addition, the SA dose-
metric of biopersistent NPs can be used for neutrophilic
inflammation because the number of neutrophils pro-
duced by Co3O4 and CoO NPs showed a significant
correlation when plotted against the SA of biopersistent
Fig. 3 Correlation between the inflammatory parameters of nanoparticles (NPs) and dose-metrics including soluble Co ions, mass, surface area
(SA), and SA dose of biopersistent NPs. Correlation between the number of eosinophils and (A) Co ions, (B) mass dose of NPs, (C) SA dose of NPs,
or (D) SA dose of biopersistent NPs. Correlation between the number of neutrophils and (E) Co ions, (F) mass dose of NPs, (G) SA dose of NPs, or
(H) SA dose of biopersistent NPs. When the dose–response curves of cobalt oxide (Co3O4) and cobalt monoxide (CoO) NPs were significantly different,
separate curves were drawn with either linear regression or non-linear regression, while when the dose–response curves of each NP overlapped, the
combined curves were prepared with best-fit regression models and the Pearson correlation test was applied. Values are mean ± SEM (n = 4) for each
treatment group
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These results also imply that the soluble fraction of
NPs is the main contributor of eosinophilic inflamma-
tion, cell death, and vascular permeability, while the
SA of biopersistent NPs is the main contributor of
neutrophilic inflammation.
Conclusions
Instillation of two types of Co-based NPs produced
different types of inflammation, neutrophilic or eosino-
philic inflammation for Co3O4 and CoO NPs, respectively.
The eosinophilic inflammation was produced by the dis-
solved Co ions inside of cells, and thus the appropriate
dose-metric for eosinophil influx, cell death, and vas-
cular permeability is the ion metric. On the other
hand, neutrophilic inflammation was developed due
to the role of biopersistent NPs, and the appropriate
dose-metric for neutrophil influx should be the SA metric
of biopersistent NPs.Methods
NPs and physicochemical characterization
Co3O4 and CoO NPs were selected as cobalt-based
NPs to evaluate both the role of solubility for NPs
and dose-metric for high-solubility NPs. Both NPs
were purchased from Nanostructured & Amorphous
Materials Inc., (NanoAmor; Houston, TX, USA). The
primary size of the NPs was measured by TEM
(JEM-1200EX II, JEOL, Tokyo, Japan). The SA of
Co3O4 NPs was measured by ParticlesCIC Ltd. (Leeds,
UK) using a Micromeritics Tristar 3000 analyzer
(Micromeritics Ltd., Bedfordshire, UK) and the SA of
CoO NPs was measured by Center for Collaborative
Instruments at Ulsan National Institute of Science
and Technology (Ulsan, Korea) using a ASAP 2420
(Micromertics Ltd.). The average size was obtained by
measuring at least 100 particles using a built-in image
analyzer program (JEOL). The hydrodynamic size,
polydispersity, and zeta potential of NPs in DW or
Fig. 4 Correlation between the toxic parameters [the levels of lactate dehydrogenase (LDH) and total protein] of nanoparticles (NPs) and
dose-metrics, including soluble cobalt (Co) ions, mass, surface area (SA), and SA dose of biopersistent NPs. Correlation between the levels of
LDH and (A) Co ions, (B) mass dose of NPs, (C) SA dose of NPs, or (D) SA dose of biopersistent NPs. Correlation between the levels of total protein
and (E) Co ions, (F) mass dose of NPs, (G) SA dose of NPs, or (H) SA dose of biopersistent NPs. When the dose–response curves of cobalt oxide
(Co3O4) and cobalt monoxide (CoO) NPs were significantly different, separate curves were drawn with either linear regression or non-linear regression,
while when the dose–response curves of each NP overlapped, the combined curves were prepared with best-fit regression models, and the Pearson
correlation test was applied. Values are mean ± SEM (n = 4) for each treatment group
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Malvern Hills, UK). The levels of endotoxin were measured
in NPs dispersed in sterile PBS at 800 μg/mL, which is
equivalent to 400 μg/rat, the highest dose for an animal
study, using an endpoint chromogenic Limulus Amebocyte
lysate (LAL) assay kit (Cambrex, Walkersville, MD, USA).
The detection limit of the LAL kit was 0.1 EU/mL.
NP solubility test
Evaluation of solubility is essential to understand the
role of soluble fractions in NP toxicity. The solubility is
variable depending on their environment. Therefore, in
our study we incubated NPs with either ALF (55 mM
NaCl, 150 mM NaOH, 108 mM citric acid, 0.87 mM
CaCl2, 0.67 mM Na2HPO4 · 7H2O, 0.27 mM Na2SO4,
0.52 mM MgCl2 · 6H2O, 0.64 mM glycerin, 0.26 mM
sodium citrate dihydrate, 0.39 mM sodium tartrate
dihydrate, 0.76 mM sodium lactate, 0.78 mM sodium
pyruvate, 1 mL of formaldehyde, pH 5.5) [19] or PBS,pH 7.4 at 100 μg/mL for 24 h at room temperature.
After incubation, NP-free supernatant was collected
using three rounds of centrifugation at 15,000 g for
30 min. The concentration of soluble cobalt ions was
measured by the Center for Collaborative Instruments
at Dong-A University (Busan, Korea) using inductively
coupled mass spectrometry (ICP-MS) (Hewlett-Packard
4500; Yokogawa, Japan). The fraction of solubilized cobalt
ions was calculated and expressed as a percentage by
dividing the mass of cobalt ions by the initial mass of
cobalt in Co3O4 or CoO NPs.
Intratracheal instillation of NPs
The intratracheal instillation model was selected instead
of an inhalation study because the former is an easy and
reliable method to identify NP toxicity and compare
responses to different particle types [32]. NP suspensions
at 80, 200, and 800 μg/mL were prepared by dispersing
NPs in sterile Ca2+- and Mg2+-free PBS (Life Technologies,
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bath sonicator (Saehan-Sonic, Seoul, Korea) to break up
agglomerates. NP suspensions were prepared and sonicated
immediately before use as recommend in a previous study
[33]. Six-week-old specific-pathogen-free female rats were
purchased from Samtako (Gyeonggi-do, Korea), main-
tained, and handled according to the policies approved by
the Institutional Animal Care and Use Committee of
Dong-A University. The instillation (n = 4 per group) was
performed according to a previously described method
[24]. NP suspensions were instilled at doses of 40, 100, and
400 μg/rat by instilling 0.5 mL of the suspensions.
Preparation of BALF
Twenty-four hour post-instillation, the rats were euthanized
via an intraperitoneal injection of tiletamine-zolazepam
(Zoletil®, 50 mg/kg) and xylazine (5 mg/kg). The trachea
was cannulated with a blunt 14 gauge needle, and the lungs
were lavaged in situ four times with cold sterile Ca2+- and
Mg2+-free PBS (Life Technologies) at a volume of 8 mL.
The first lavage was kept for analysis of LDH, total protein,
and pro-inflammatory cytokines. Cell pellets from
four lavages were pooled for cell counts. The total
number of cells in the BALF was quantified by a
nucleocounter (Chemometec, Allerod, Denmark), and
4 × 104 cells were attached to glass slides by cytospin at 27 g
for 5 min. The cells were then fixed for 5 min with
methanol and stained with Diff-Quik (Thermo Fisher
Scientific, Waltham, MA, USA) for the differential
cell count.
Analysis of BALF
To evaluate the inflammogenicity using cytological analysis,
differential cell counts were performed by counting a
minimum of 300 cells under a light microscope (Nikon,
Tokyo, Japan). The levels of LDH, a marker for cytotoxicity,
were measured in the BALF using an LDH assay kit (Roche
Diagnostics, Mannheim, Germany). The concentrations of
total protein, a maker for vascular permeability, were
measured in the BALF using a bicinchoninic acid (BCA)
assay kit (Thermo Fisher Scientific). To evaluate the role of
pro-inflammatory cytokines in NP-induced inflammation,
CINC-3, eotaxin, IL-1β, IL-6, IL-13, and TNF-α, all from
the Duoset ELISA kit (R&D Systems, Minneapolis,
MN, USA), were measured in the BALF according to the
manufacturer’s protocol.
Instillation of Co ions into the lungs of rats
In our previous study, we found that the eosinophilic
inflammation by ZnO NPs was attributed to its high
solubility in lysosomal fluid [16]. Because CoO NPs
showed a high solubility in ALF and significantly recruited
eosinophils, CoCl2 was used to further investigate the
role of the dissolved Co ions from CoO NPs. CoCl2(Sigma-Aldrich, St. Louis, MO, USA) was solubilized in a
sterile solution of 0.9 % saline, because Co ions can easily
precipitate in a phosphate solution by forming cobalt
phosphate, Co3(PO4)2, which is insoluble in DW. The
concentrations of CoCl2 for instillation were 69, 173, and
693 μg/rat, which were the equivalent Co ion doses for 40,
100, and 400 μg/rat of CoO NPs, respectively. As a vehicle
control, 500 μL of saline was instilled.Evaluation of appropriate dose-metric
There are many metrics should be regarded for dose–
response curves. To our knowledge, dose can be divided
into treatment-related dose (mass, number, or SA) and
particle-derived dose (surface charge, oxidative potential,
solubility, or soluble toxins). In this study, we used Co3O4
and CoO, two types of cobalt-based NPs, which have
similar types of soluble fractions but different solubility to
evaluate the dose-metric or response metric for acute lung
inflammation pattern. Regarding the treatment-related
dose, number of particles was excluded because particle
number is the worst to describe NP-induced pulmonary
inflammatory effects [6]. Regarding the particle-derived
dose, surface charge and oxidative potential was excluded
not only because we focused on the solubility issue but
also the surface charge or oxidative potential is a moving
target for high solubility NPs. For this reason, we treated
two-cobalt based NPs with a mass metric and con-
verted to several possible dose metrics such as mass
of NPs, SA of NPs, soluble fraction of Co ions, or SA
of biopersistent NPs. The SA of biopersistent NPs
was mathematically calculated by multiplying the ratio
of dissolution by the SA of instilled NPs. The appropriate
dose-metrics were then plotted against the parameters
for lung inflammogenicity, including total cells, differential
cell counts, LDH, total protein, and pro-inflammatory
cytokines. When the dose–response curves of Co3O4
and CoO NPs were significantly different, separate
curves were drawn with either linear regression or
non-linear regression using GraphPad Prism Software
(GraphPad Prism version 6 for Windows; GraphPad
Software, Inc., San Diego, CA, USA). However, when the
dose–response curve of each NP was overlapped,
combined curves were prepared with best-fit regres-
sion models, and the Pearson correlation test was
applied.Statistical analysis
Data were expressed as mean ± SEM (n = 4). We analyzed
statistical differences using one-way analysis of variance
(ANOVA) followed by post-hoc Tukey’s pairwise com-
parisons using GraphPad Prism Software (GraphPad
Prism version 6 for Windows). The value of p < 0.05
considered statistically significant.
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